| Product Name | NebuSelect™ Recombinant Mouse ALK, hFc-tag |
|---|---|
| Catalog Number | NBL-243115 |
| Alias/Synonyms | ALK; ALK tyrosine kinase receptor; Anaplastic lymphoma kinase; CD246; |
| Appearance | see COA |
| Molecule Weight | Ser19-Cys692 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P97793 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-243115-100ug | 100ug | Inquire | Inquire | |
| NBL-243115-1mg | 1mg | Inquire | Inquire | |
| NBL-243115-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse ALK, hFc-tag
Catalog#:
NBL-243115
Description:
NebuSelect™ Recombinant Mouse ALK, hFc-tag(Cat#NBL-243115) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Ser19-Cys692.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 101.11 kDa. Due to glycosylation, the protein migrates to 115-125 kDa based on Bis-Tris PAGE result.
Target Name:
ALK; ALK tyrosine kinase receptor; Anaplastic lymphoma kinase; CD246;
Target Information:
Anaplastic lymphoma kinase (ALK) is mostly known for its oncogenic role in several human cancers. Recent evidences clearly indicate new roles of ALK and its genetic aberrations (e.g. gene rearrangements and mutations) in immune evasion, innate and cell-mediated immunity. New ALK-related immunotherapy approaches are demonstrating both preclinical and clinical promises.
Amino Acid Sequence:
Ser19-Cys692
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.